Seeking Alpha

Questcor Pharmaceuticals (QCOR +13.07%) sits idle in the post session today as the company gets...

Questcor Pharmaceuticals (QCOR +13.07%) sits idle in the post session today as the company gets its presentation at the BofA/Merrill health-care conference underway. While not likely to provide any sweeping new information, the presentation will paint a clearer picture of what lies ahead for Acthar gel in the realm of an alternative treatment for certain rheumatology-related conditions. According to Janney Montgomery spelling out the numbers of patients needing alternative treatment could what drove some shorts to cover today. Short interest on the stock stands at about 45%.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector